Mesplède T - Search Results

1

Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay.

Han YS, Penthala NR, Oliveira M, Mesplède T, Xu H, Quan Y, Crooks PA, Wainberg MA. Han YS, et al. Among authors: mesplede t. J Med Virol. 2017 Mar;89(3):397-407. doi: 10.1002/jmv.24660. Epub 2016 Aug 22. J Med Virol. 2017. PMID: 27509184

2

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.

Oliere S, Arguello M, Mesplede T, Tumilasci V, Nakhaei P, Stojdl D, Sonenberg N, Bell J, Hiscott J. Oliere S, et al. Among authors: mesplede t. J Virol. 2008 Jun;82(12):5735-49. doi: 10.1128/JVI.02601-07. Epub 2008 Apr 16. J Virol. 2008. PMID: 18417567 Free PMC article.

3

IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis.

Nakhaei P, Sun Q, Solis M, Mesplede T, Bonneil E, Paz S, Lin R, Hiscott J. Nakhaei P, et al. Among authors: mesplede t. J Virol. 2012 Jan;86(2):726-37. doi: 10.1128/JVI.05989-11. Epub 2011 Nov 9. J Virol. 2012. PMID: 22072751 Free PMC article.

4

Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir.

Quashie PK, Mesplède T, Han YS, Oliveira M, Singhroy DN, Fujiwara T, Underwood MR, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. J Virol. 2012 Mar;86(5):2696-705. doi: 10.1128/JVI.06591-11. Epub 2011 Dec 28. J Virol. 2012. PMID: 22205735 Free PMC article.

5

A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.

Han YS, Quashie P, Mesplede T, Xu H, Mekhssian K, Fenwick C, Wainberg MA. Han YS, et al. Among authors: mesplede t. J Virol Methods. 2012 Sep;184(1-2):34-40. doi: 10.1016/j.jviromet.2012.05.003. Epub 2012 May 11. J Virol Methods. 2012. PMID: 22584270

6

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

Schader SM, Colby-Germinario SP, Quashie PK, Oliveira M, Ibanescu RI, Moisi D, Mespléde T, Wainberg MA. Schader SM, et al. Among authors: mesplede t. Antimicrob Agents Chemother. 2012 Aug;56(8):4257-67. doi: 10.1128/AAC.00639-12. Epub 2012 May 21. Antimicrob Agents Chemother. 2012. PMID: 22615295 Free PMC article.

7

Resistance to HIV integrase inhibitors.

Mesplède T, Quashie PK, Wainberg MA. Mesplède T, et al. Curr Opin HIV AIDS. 2012 Sep;7(5):401-8. doi: 10.1097/COH.0b013e328356db89. Curr Opin HIV AIDS. 2012. PMID: 22789986 Review.

8

The development of novel HIV integrase inhibitors and the problem of drug resistance.

Wainberg MA, Mesplède T, Quashie PK. Wainberg MA, et al. Among authors: mesplede t. Curr Opin Virol. 2012 Oct;2(5):656-62. doi: 10.1016/j.coviro.2012.08.007. Epub 2012 Sep 16. Curr Opin Virol. 2012. PMID: 22989757 Review.

9

HIV Drug Resistance and the Advent of Integrase Inhibitors.

Quashie PK, Mesplède T, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. Curr Infect Dis Rep. 2013 Feb;15(1):85-100. doi: 10.1007/s11908-012-0305-1. Curr Infect Dis Rep. 2013. PMID: 23180144

10

Evolution of HIV integrase resistance mutations.

Quashie PK, Mesplède T, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. Curr Opin Infect Dis. 2013 Feb;26(1):43-9. doi: 10.1097/QCO.0b013e32835ba81c. Curr Opin Infect Dis. 2013. PMID: 23242340 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page